SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-16-030392
Filing Date
2016-04-29
Accepted
2016-04-29 16:15:49
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A dffn20160428_10ka.htm 10-K/A 568822
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10201
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10262
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5716
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5972
  Complete submission text file 0001437749-16-030392.txt   602303
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-24477 | Film No.: 161606768
SIC: 2834 Pharmaceutical Preparations